Duyster J - Search Results

1

Combination of Lenvatinib and Pembrolizumab Is an Effective Treatment Option for Anaplastic and Poorly Differentiated Thyroid Carcinoma.

Dierks C, Seufert J, Aumann K, Ruf J, Klein C, Kiefer S, Rassner M, Boerries M, Zielke A, la Rosee P, Meyer PT, Kroiss M, Weißenberger C, Schumacher T, Metzger P, Weiss H, Smaxwil C, Laubner K, Duyster J, von Bubnoff N, Miething C, Thomusch O. Dierks C, et al. Among authors: duyster j. Thyroid. 2021 Jul;31(7):1076-1085. doi: 10.1089/thy.2020.0322. Epub 2021 Apr 15. Thyroid. 2021. PMID: 33509020 Free PMC article.

2

BCR-ABL gene mutations in relation to clinical resistance of Philadelphia-chromosome-positive leukaemia to STI571: a prospective study.

von Bubnoff N, Schneller F, Peschel C, Duyster J. von Bubnoff N, et al. Among authors: duyster j. Lancet. 2002 Feb 9;359(9305):487-91. doi: 10.1016/S0140-6736(02)07679-1. Lancet. 2002. PMID: 11853795

3

Resistance of Philadelphia-chromosome positive leukemia towards the kinase inhibitor imatinib (STI571, Glivec): a targeted oncoprotein strikes back.

von Bubnoff N, Peschel C, Duyster J. von Bubnoff N, et al. Among authors: duyster j. Leukemia. 2003 May;17(5):829-38. doi: 10.1038/sj.leu.2402889. Leukemia. 2003. PMID: 12750693 Review.

4

A cell-based screening strategy that predicts mutations in oncogenic tyrosine kinases: implications for clinical resistance in targeted cancer treatment.

von Bubnoff N, Barwisch S, Speicher MR, Peschel C, Duyster J. von Bubnoff N, et al. Among authors: duyster j. Cell Cycle. 2005 Mar;4(3):400-6. doi: 10.4161/cc.4.3.1560. Epub 2005 Mar 25. Cell Cycle. 2005. PMID: 15738656 Review.

5

The Bcr-Abl mutations T315I and Y253H do not confer a growth advantage in the absence of imatinib.

Miething C, Feihl S, Mugler C, Grundler R, von Bubnoff N, Lordick F, Peschel C, Duyster J. Miething C, et al. Among authors: duyster j. Leukemia. 2006 Apr;20(4):650-7. doi: 10.1038/sj.leu.2404151. Leukemia. 2006. PMID: 16482207

6

Bcr-Abl resistance screening predicts a limited spectrum of point mutations to be associated with clinical resistance to the Abl kinase inhibitor nilotinib (AMN107).

von Bubnoff N, Manley PW, Mestan J, Sanger J, Peschel C, Duyster J. von Bubnoff N, et al. Among authors: duyster j. Blood. 2006 Aug 15;108(4):1328-33. doi: 10.1182/blood-2005-12-010132. Epub 2006 Apr 13. Blood. 2006. PMID: 16614241 Free article.

7

Targeting the oncogenic tyrosine kinase NPM-ALK in lymphoma: the role of murine models in defining pathogenesis and treatment options.

Miething C, Peschel C, Duyster J. Miething C, et al. Among authors: duyster j. Curr Drug Targets. 2006 Oct;7(10):1329-34. doi: 10.2174/138945006778559229. Curr Drug Targets. 2006. PMID: 17073594 Review.

8

Imatinib and leptomycin B are effective in overcoming imatinib-resistance due to Bcr-Abl amplification and clonal evolution but not due to Bcr-Abl kinase domain mutation.

Kancha RK, von Bubnoff N, Miething C, Peschel C, Götze KS, Duyster J. Kancha RK, et al. Among authors: duyster j. Haematologica. 2008 Nov;93(11):1718-22. doi: 10.3324/haematol.13207. Epub 2008 Aug 25. Haematologica. 2008. PMID: 18728023 Free article.

9

Functional analysis of epidermal growth factor receptor (EGFR) mutations and potential implications for EGFR targeted therapy.

Kancha RK, von Bubnoff N, Peschel C, Duyster J. Kancha RK, et al. Among authors: duyster j. Clin Cancer Res. 2009 Jan 15;15(2):460-7. doi: 10.1158/1078-0432.CCR-08-1757. Clin Cancer Res. 2009. PMID: 19147750

10

Oncologist's/haematologist's view on the roles of pathologists for molecular targeted cancer therapy.

Keller U, von Bubnoff N, Peschel C, Duyster J. Keller U, et al. Among authors: duyster j. J Cell Mol Med. 2010 Apr;14(4):805-17. doi: 10.1111/j.1582-4934.2010.01032.x. Epub 2010 Feb 16. J Cell Mol Med. 2010. PMID: 20158573 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

281 results

Search Page